<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Barba L</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>e16581</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11664725</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>32(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>We aimed to investigate the prognostic role of β-synuclein in comparison to that of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) for predicting functional outcome after acute ischemic stroke (AIS).&lt;h4>Methods&lt;/h4>We measured serum concentrations of β-synuclein, NfL and GFAP 24 h after hospital admission in 213 consecutive patients with moderate-to-severe AIS. We investigated the association between serum biomarkers and radiological/clinical characteristics, 3-months mortality and functional outcome on the modified Rankin Scale (mRS).&lt;h4>Results&lt;/h4>In 213 patients with AIS [mean age: 76.1 (±12.5) years, 53.1% males, median NIHSS score on admission: 13 (IQR: 9-17)], higher levels of β-synuclein, NfL and GFAP were associated with higher NIHSS </pubmed_abstract><journal>European journal of neurology</journal><pubmed_title>Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation.</pubmed_title><pmcid>PMC11664725</pmcid><funding_grant_id>SFB1279</funding_grant_id><funding_grant_id>374031971 - TRR 240</funding_grant_id><funding_grant_id>413657723</funding_grant_id><pubmed_authors>Hametner C</pubmed_authors><pubmed_authors>D'Anna L</pubmed_authors><pubmed_authors>Abu-Rumeileh S</pubmed_authors><pubmed_authors>Halbgebauer S</pubmed_authors><pubmed_authors>Kollikowski AM</pubmed_authors><pubmed_authors>Heuschmann PU</pubmed_authors><pubmed_authors>Haeusler KG</pubmed_authors><pubmed_authors>Vollmuth C</pubmed_authors><pubmed_authors>Romoli M</pubmed_authors><pubmed_authors>Otto M</pubmed_authors><pubmed_authors>Barba L</pubmed_authors><pubmed_authors>Schuhmann MK</pubmed_authors><pubmed_authors>Stoll G</pubmed_authors><pubmed_authors>Ungethum K</pubmed_authors><pubmed_authors>Oeckl P</pubmed_authors><pubmed_authors>Essig F</pubmed_authors><pubmed_authors>Steinacker P</pubmed_authors><pubmed_authors>Pham M</pubmed_authors><pubmed_authors>Neugebauer H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation.</name><description>&lt;h4>Background&lt;/h4>We aimed to investigate the prognostic role of β-synuclein in comparison to that of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) for predicting functional outcome after acute ischemic stroke (AIS).&lt;h4>Methods&lt;/h4>We measured serum concentrations of β-synuclein, NfL and GFAP 24 h after hospital admission in 213 consecutive patients with moderate-to-severe AIS. We investigated the association between serum biomarkers and radiological/clinical characteristics, 3-months mortality and functional outcome on the modified Rankin Scale (mRS).&lt;h4>Results&lt;/h4>In 213 patients with AIS [mean age: 76.1 (±12.5) years, 53.1% males, median NIHSS score on admission: 13 (IQR: 9-17)], higher levels of β-synuclein, NfL and GFAP were associated with higher NIHSS </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-03T23:13:54.089Z</modification><creation>2025-04-03T23:13:54.089Z</creation></dates><accession>S-EPMC11664725</accession><cross_references><pubmed>39714176</pubmed><doi>10.1111/ene.16581</doi></cross_references></HashMap>